AAAAI 2020: Dual Biologic Therapy Appears Safe in Small Subset of Patients
There were no increased incidences of serum sickness, adverse events, increased immune suppression, or infections
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.